UK markets closed

Arrowhead Pharmaceuticals, Inc. (ARWR)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
47.29+1.66 (+3.64%)
At close: 04:00PM EDT
48.52 +1.23 (+2.60%)
After hours: 07:48PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close45.63
Open46.16
Bid47.00 x 900
Ask48.00 x 1400
Day's range46.06 - 47.90
52-week range26.81 - 84.83
Volume604,039
Avg. volume835,722
Market cap5.006B
Beta (5Y monthly)1.35
PE ratio (TTM)N/A
EPS (TTM)-1.08
Earnings date04 Aug 2022
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est77.25
  • Motley Fool

    Arrowhead Pharmaceuticals (ARWR) Q3 2022 Earnings Call Transcript

    Thank you for joining us today to discuss Arrowhead's results for its fiscal 2022 third quarter ended June 30, 2022. With us today from management are president and CEO, Dr. Christopher Anzalone, who will provide an overview of the quarter; Dr. Javier San Martin, our chief medical officer, who will provide an update on our mid-and later-stage clinical pipeline; Dr. James Hamilton, our senior vice president of Discovery and Translational Medicine, who will provide an update on our earlier stage programs; and Ken Myszkowski, our chief financial officer, who will give a review of the financials.

  • Business Wire

    Arrowhead Pharmaceuticals Reports Fiscal 2022 Third Quarter Results

    PASADENA, Calif., August 04, 2022--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced financial results for its fiscal third quarter ended June 30, 2022. The company is hosting a conference call today, August 4, 2022, at 4:30 p.m. ET to discuss the results.

  • Business Wire

    Arrowhead Pharmaceuticals to Webcast Fiscal 2022 Third Quarter Results

    PASADENA, Calif., July 20, 2022--Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that it will host a webcast and conference call on August 4, 2022, at 4:30 p.m. ET to discuss its financial results for the fiscal 2022 third quarter ended June 30, 2022.